Treatment of Brain AVMs (TOBAS) Study

Launched by CENTRE HOSPITALIER DE L'UNIVERSITÉ DE MONTRÉAL (CHUM) · Mar 25, 2014

Keywords

ClinConnect Summary

The TOBAS Study is researching the best ways to treat brain arteriovenous malformations (AVMs), which are abnormal connections between blood vessels in the brain. This study aims to find out if medical management or certain treatments, like surgery or radiation, can lower the risk of death or serious stroke in patients with unruptured AVMs. They hope to see a significant improvement in safety and effectiveness when using endovascular procedures, which involve guiding a small tube through blood vessels to treat the AVM.

To participate in this study, you need to be at least 18 years old and have a brain AVM. However, if you are experiencing severe symptoms from a bleeding AVM that requires immediate surgery, you won’t be eligible. If you join the trial, you will receive careful monitoring and treatment options tailored to your situation. The study is currently looking for participants, and everyone’s involvement could help improve future treatments for this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Any patient with a brain AVM
• Exclusion Criteria:
• • Hemorrhagic presentation with mass effect requiring surgical management. In these cases, if a residual AVM is found after the initial surgery, the patient could then be a candidate for TOBAS.